Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting

There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.  

This activity involves three discussants using case-based presentations to review recent advances in breast cancer treatment. The first discussant addresses when to treat early-stage breast cancer patients, including a review of the recent ASTRO APBI guidelines and the IDEA and Lumina 1 trial. The second discussant examines radiation therapy in the post-neoadjuvant setting, including an assessment of the NSABP B-51 results. The third discussant assesses indications and techniques for using breast IMRT.

Topics:

  1. To Treat or Not to Treat: Patients with Early-Stage Breast Cancer
    Janice Lyons, MD
  2. Radiation Therapy for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Lisa Singer, MD, PhD
  3. Indications and Techniques for Breast IMRT
    Laura E.G. Warren, MD, EdM
  4. Q and A
    Christine S. Chung, MD, MPH, FASTRO - Moderator
    Full Panel

This activity is available from March 4, 2025, through 11:59 p.m. Eastern time on March 3, 2027. 

The content was originally presented and recorded at the 2024 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of medical oncologists and radiation oncologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss treatment options for patients with early-stage breast cancer and those treated with neoadjuvant chemotherapy. 
  • Discuss indications and treatment techniques for IMRT in breast cancer patients.
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
03/04/2025
Course expires: 
03/03/2027
Cost:
$149.00
Rating: 
0
  • Christine S. Chung, MD, MPH, FASTRO, is employed by H. Lee Moffitt Cancer Center. 
  • Janice Lyons, MD, is employed by University Hospitals Seidman Cancer Center/Case Western Reserve University/University Hospitals of Cleveland. Dr. Lyons receives honoraria from Primum. Dr. Lyons serves in uncompensated roles with ASTRO as Chair of the PBI Guideline Committee, NCCN as a member of the breast cancer guideline committee and ABR as a member of the exam development committee.
  • Lisa Singer, MD, PhD, is employed by University of California, San Francisco. Dr. Singer receives grant/research funding from UCSF PIPE. Dr. Singer serves on the Board of Directors with the American Board of MR Safety.  
  • Laura E.G. Warren, MD, EdM, is employed by the Dana-Farber Cancer Institute and the Brigham and Women’s Physician Organization.

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $149
  • Member: $99
  • Member-in-Training: $49
  • Student/Graduate Student/PGY-1 Member: $49
  • Postdoctoral Fellow Member: $49

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until March 3, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.